Sofinnova Investments as of March 31, 2019
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 67 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 11.3 | $118M | 999k | 117.70 | |
| Amarin Corporation | 10.4 | $108M | 5.2M | 20.76 | |
| Principia Biopharma | 6.7 | $69M | 2.0M | 34.00 | |
| Natera (NTRA) | 6.2 | $64M | 3.1M | 20.62 | |
| Obseva Sa | 5.9 | $61M | 4.7M | 12.79 | |
| Y Mabs Therapeutics | 5.3 | $55M | 2.1M | 26.21 | |
| Spark Therapeutics | 5.3 | $55M | 481k | 113.88 | |
| Nucana Biomed ordinary shares | 3.9 | $41M | 2.4M | 17.00 | |
| Coherus Biosciences (CHRS) | 3.8 | $39M | 2.9M | 13.64 | |
| Nucana Plc american depositary shares | 3.7 | $39M | 2.3M | 17.00 | |
| Audentes Therapeutics | 3.5 | $36M | 934k | 39.02 | |
| Merus N V (MRUS) | 2.8 | $29M | 2.0M | 14.77 | |
| Ishares Tr Index option | 2.6 | $27M | 242k | 111.79 | |
| Kiniksa Pharmaceuticals | 1.6 | $17M | 923k | 18.06 | |
| Iterum Therapeutics | 1.3 | $14M | 1.7M | 7.92 | |
| Novo Nordisk A/S (NVO) | 1.2 | $13M | 248k | 52.31 | |
| Allergan | 1.2 | $13M | 89k | 146.40 | |
| Abbvie (ABBV) | 1.2 | $12M | 150k | 80.59 | |
| Aclaris Therapeutics (ACRS) | 1.1 | $12M | 1.9M | 5.99 | |
| AstraZeneca (AZN) | 1.0 | $11M | 262k | 40.42 | |
| Alnylam Pharmaceuticals (ALNY) | 1.0 | $10M | 107k | 93.46 | |
| Neurocrine Biosciences (NBIX) | 0.9 | $9.9M | 112k | 88.12 | |
| Biogen Idec (BIIB) | 0.9 | $9.5M | 40k | 236.33 | |
| Macrogenics (MGNX) | 0.9 | $9.4M | 524k | 17.98 | |
| Chiasma | 0.8 | $8.5M | 1.6M | 5.20 | |
| Amicus Therapeutics (FOLD) | 0.8 | $7.9M | 584k | 13.60 | |
| Entasis Therapeutics Holdings Ord | 0.8 | $8.0M | 1.2M | 6.75 | |
| Anaptysbio Inc Common (ANAB) | 0.7 | $7.2M | 98k | 73.03 | |
| Xencor (XNCR) | 0.6 | $6.5M | 210k | 31.05 | |
| Dermira | 0.6 | $6.6M | 484k | 13.55 | |
| Halozyme Therapeutics (HALO) | 0.6 | $6.5M | 401k | 16.10 | |
| Biohaven Pharmaceutical Holding | 0.6 | $6.4M | 125k | 51.48 | |
| Morphosys (MPSYF) | 0.6 | $6.3M | 69k | 91.01 | |
| Heron Therapeutics (HRTX) | 0.6 | $5.7M | 234k | 24.43 | |
| Blueprint Medicines (BPMC) | 0.6 | $5.8M | 72k | 80.03 | |
| Reata Pharmaceuticals Inc Cl A | 0.5 | $5.6M | 65k | 85.51 | |
| Savara (SVRA) | 0.5 | $5.7M | 767k | 7.37 | |
| Intercept Pharmaceuticals In | 0.5 | $5.0M | 45k | 111.82 | |
| Deciphera Pharmaceuticals | 0.5 | $5.0M | 215k | 23.21 | |
| Orchard Therapeutics Plc ads | 0.5 | $4.9M | 276k | 17.89 | |
| Incyte Corporation (INCY) | 0.4 | $4.6M | 53k | 86.06 | |
| Kadmon Hldgs | 0.4 | $4.4M | 1.7M | 2.64 | |
| Synlogic | 0.4 | $4.4M | 575k | 7.59 | |
| Akebia Therapeutics (AKBA) | 0.4 | $4.2M | 517k | 8.19 | |
| Insmed (INSM) | 0.4 | $4.1M | 140k | 29.08 | |
| Puma Biotechnology (PBYI) | 0.3 | $3.6M | 94k | 38.79 | |
| Fate Therapeutics (FATE) | 0.3 | $3.6M | 204k | 17.58 | |
| Gw Pharmaceuticals Plc ads | 0.3 | $3.4M | 20k | 168.48 | |
| Fibrogen | 0.3 | $3.2M | 59k | 54.36 | |
| Foamix Pharmaceuticals | 0.3 | $3.1M | 832k | 3.75 | |
| Xbiotech (XBIT) | 0.3 | $2.9M | 261k | 11.01 | |
| Kala Pharmaceuticals | 0.3 | $2.9M | 345k | 8.27 | |
| Tg Therapeutics (TGTX) | 0.3 | $2.8M | 352k | 8.05 | |
| Otonomy | 0.3 | $2.7M | 1.0M | 2.63 | |
| Fibrogen | 0.3 | $2.7M | 50k | 54.40 | |
| Galapagos Nv- (GLPG) | 0.2 | $2.4M | 20k | 117.67 | |
| BioMarin Pharmaceutical (BMRN) | 0.2 | $1.6M | 19k | 88.70 | |
| ArQule | 0.2 | $1.7M | 356k | 4.79 | |
| Clovis Oncology | 0.2 | $1.7M | 67k | 24.81 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $1.1M | 213k | 5.26 | |
| Portola Pharmaceuticals | 0.1 | $1.0M | 30k | 34.71 | |
| Pds Biotechnology Ord (PDSB) | 0.1 | $1.1M | 143k | 7.40 | |
| Apellis Pharmaceuticals (APLS) | 0.1 | $967k | 50k | 19.50 | |
| Osmotica Pharmaceuticals (RVLPQ) | 0.1 | $911k | 253k | 3.60 | |
| Adverum Biotechnologies | 0.1 | $838k | 159k | 5.26 | |
| ImmunoGen | 0.0 | $405k | 150k | 2.70 | |
| Conatus Pharmaceuticals | 0.0 | $161k | 150k | 1.07 |
